- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01349166
Effects of 3 Months of Supervised Exercise Training
Effects of 3 Months of Supervised Exercise Training on Cardiometabolic and Inflammatory Biomarkers According to Glucose Tolerance (Normal, Intolerance and Type 2 Diabetes): Measures in Unstimulated and Stimulated Conditions
The incidence of type 2 diabetes is increasing worldwide. Because of cardiovascular morbidity and mortality associated with type 2 diabetes, it is imperative to propose methods of prevention and this in early stage of abnormal glucose metabolism.
This study will assess the beneficial effects of physical activity (acute and chronic effects) (the subjects being their own controls) on cardiometabolic and inflammatory biomarkers in 3 conditions : unstimulated (fasting and resting conditions) and stimulated conditions: postprandial response to a standardized meal preceded or not by an exercise bout.
The investigators hypothesized that an acute bout of exercise will decrease the postprandial inflammatory response to a standardized meal and that this effect of exercise will be increased after 3 months of exercise training.
Study Overview
Status
Intervention / Treatment
Detailed Description
This is a prospective study over 4 months, open, nonrandomized. 45 overweight or obese male subjects will complete 3 experimental sessions (0700-1400h) before and after 3 months of supervised physical training. During a first session, subjects will remain inactive and fasted (basal conditions). During the second session a standardized meal will be offered (postprandial response to a standardized meal). The third session will consist in the realization of an exercise bout (60min at 60%VO2 max) followed by a standardized meal (same meal that the previous day).
Several blood (catheter), salivary and urinary samples will be collected during the 3 sessions, throughout the experimental day.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male Caucasian Adults between 30 and 65 years old Sedentary criteria based on the determination of fasting glucose (WHO 1999):
- normal if fasting plasma glucose (FPG) <1.10 g / l
- diabetes if fasting glucose> 1.26 g / l (7 mmol / l) twice
- nondiabetic fasting hyperglycemia: 1.10 g / l ≤ FPG ≤ 1.26 g / l
- glucose intolerance : if plasma glucose at 120 minutes during the OGTT (75g) is between 1.40 g / l and 2 g/ l.
Body mass index 25 BMI 35kg/m2 Affiliated to National Health Insurance Subject giving his written informed consent Subject considered as normal after clinical examination and medical questionnaire
Exclusion Criteria:
- - drugs that interfere with the parameters determined
- diabetic treated with insulin, glitazones or glinides
- eating disorders like bulimia and vomiting
- special diet, vegan or vegetarian
- autoimmune disease or inflammatory progressive desease requiring prolonged treatment
- regular physical activity (> 1 hour of physical activity per week for at least 6 months)
- smoking (> 5 cigarettes / day)
- weight change greater than 5% of the total weight in the 3 months preceding the study
- contra-indication to physical activity
- chronic pathologies: cancer, inflammatory, cardiac, pulmonary, renal, gastrointestinal or liver diseases
- Being in exclusion on the National Volunteers Data file
- No one under guardianship or not subject to social security.
- Being under someone's supervision
- Subjects deprived of their liberty by judicial or administrative.
- Refusal to sign the information sheet and written consent for particip
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
supervised physical training on cardiometabolic and inflammatory biomarkers
Time Frame: after 3 months
|
after 3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
relationships between cortisol secretion and the postprandial inflammatory responses depending on the level of glucose tolerance
Time Frame: after 3 months
|
after 3 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-0088
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Intolerance
-
Huazhong University of Science and TechnologyRecruitingGlucose Intolerance During PregnancyChina
-
Yonsei UniversityNot yet recruitingType 2 Diabetes | Impaired Glucose Intolerance
-
University of California, IrvineUniversity of California, Davis; University of California, San FranciscoCompletedStress, Psychological | Pregnancy Related | Glucose Intolerance During PregnancyUnited States
-
Korea UniversityKorean Society of Cardiometabolic Syndrome (funder)RecruitingHyperglycemias | Postprandial Glucose | Glucose LevelsSouth Korea
-
University of OsloCompleted
-
Clinical Nutrition Research Center, Illinois Institute...CompletedImpaired Glucose ToleranceUnited States
-
Eden MillerPendulum TherapeuticsUnknownAbnormal Glucose ToleranceUnited States
-
University of MinnesotaCompleted
-
Chiang Mai UniversityKagawa UniversityCompletedImpaired Glucose ToleranceThailand
-
Shanghai General Hospital, ChinaRecruiting
Clinical Trials on Behavior: Supervised physical training
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedChronic Low Back Pain (CLBP)Canada
-
Aarhus University Hospital SkejbyInstitute for Clinical and Experimental MedicineCompletedHeart Failure | Coronary Heart Disease | Ischemic Heart DiseasesDenmark
-
Muğla Sıtkı Koçman UniversityActive, not recruitingBEHAVIOR CHANGE-BASED PHYSICAL ACTIVITY INTERVENTION IN PAD PATIENTS AFTER ENDOVASCULAR REVASCULARIZATIONTurkey (Türkiye)
-
Vastra Gotaland RegionRecruiting
-
Hacettepe UniversityCompletedCoronary Artery Disease | Physical InactivityTurkey
-
Julius-Maximilians UniversityHannover Medical School; Goethe University; Triemli Hospital; Mukoviszidose eV... and other collaboratorsCompletedCystic FibrosisGermany, Switzerland
-
University of ManchesterUnknownCardiovascular Diseases | Peripheral Arterial Disease
-
University of SevilleUniversity Hospital Virgen del Rocio, SevillaNot yet recruitingPhysical Activity | Exercise | Abdominal Wall Hernia | Prevention
-
Medical University of ViennaUnknownPeripheral Artery DiseaseAustria
-
University of VermontNational Institute of General Medical Sciences (NIGMS)CompletedType 1 DiabetesUnited States